CVS announces annual ALS campaign

WOONSOCKET, R.I. CVS/pharmacy has announced the kick off of its annual ALS Fundraising Campaign in partnership with the ALS Therapy Alliance.

To date, the pharmacy retailer has raised more than $10 million in its stores—one $1 donation at a time—to support the fundraising of new clinical trials with the hope of discovering a treatment or cure for the disease. This year’s campaign runs through June 28.

ALS is a disorder in which there is progressive degeneration of motor nerves in the brain and spinal cord leading to paralysis and death, typically three to five years. There is no known cause or cure for ALS, which affects 25,000 Americans, with 5,000 new cases diagnosed each year.

The honorary co-chairs of this year’s campaign are Jeanne Bouley, a former CVS employee and ALS patient, and Jon Roberts, senior vice president and chief information officer of CVS Caremark.

“The support from CVS/pharmacy customers for ALS is phenomenal year after year,” stated Roberts. “Our employees have rallied around the cause as well and they ask each and every customer to support ALS research during our campaign season. In this way, we have raised more than $10 million with 100 percent of donations going directly to the ALS Therapy Alliance to fund their groundbreaking research.”